Cargando…
Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer
Neuropilin-2 (NRP2) is a prognostic indicator for reduced survival in bladder cancer (BCa) patients. Together with its major ligand, vascular endothelial growth factor (VEGF)-C, NRP2 expression is a predictive factor for treatment outcome in response to radiochemotherapy in BCa patients who underwen...
Autores principales: | Schulz, Alexander, Gorodetska, Ielizaveta, Behrendt, Rayk, Fuessel, Susanne, Erdmann, Kati, Foerster, Sarah, Datta, Kaustubh, Mayr, Thomas, Dubrovska, Anna, Muders, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986262/ https://www.ncbi.nlm.nih.gov/pubmed/32038994 http://dx.doi.org/10.3389/fonc.2019.01461 |
Ejemplares similares
-
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
por: Gorodetska, Ielizaveta, et al.
Publicado: (2019) -
The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells
por: Püschel, Jakob, et al.
Publicado: (2021) -
Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse
por: Seifert, Michael, et al.
Publicado: (2019) -
NRP2 transcriptionally regulates its downstream effector WDFY1
por: Dutta, Samikshan, et al.
Publicado: (2016) -
Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases
por: Polavaram, Navatha Shree, et al.
Publicado: (2021)